Victoria Barghout

Suggest Changes
Learn More
10577 Background: The BIG 1-98 and ATAC studies demonstrated that, in postmenopausal women with hormone receptor positive (HR+) early breast cancer, 5 years of initial adjuvant therapy with the(More)
  • 1